The DOI matches its Crossref record.
Schiff's Diseases of the Liver
Abstract
The premier clinical hepatology reference for 50 years, Schiff's Diseases of the Liver is in its Tenth Edition--now in full color throughout. This edition features a major new transplant section focusing on pre-transplant and post-transplant evaluation and management. Also included are updates on key topics such as hepatitis, NASH, and drug-induced pathologies. The first third of the book covers anatomy, pathology, testing, imaging, and effects of liver disease on other organs. Subsequent sections address specific diseases and clinical syndromes. Each of the 12 sections begins with an overview, and each chapter starts with an outline of key concepts. Numerous clinical algorithms appear throughout the text.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Pulmonary–Hepatic vascular Disorders (PHD)
Rodríguez-Roisin, R., Krowka, M. J., Hervé, P., & Fallon, M. B. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00010904 · Cited by 796
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.31 · Cited by 589
Burden of liver disease in the United States: Summary of a workshop
Kim, R. W., Brown, R. S., Terrault, N. A., & El-Serag, H. (2002) · Hepatology · doi:10.1053/jhep.2002.34734 · Cited by 589
AGA technical review on the evaluation of liver chemistry tests
Green, R. M., & Flamm, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.36061 · Cited by 587
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
McCullough, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.004 · Cited by 580
Worldwide trends in mortality from biliary tract malignancies
Patel, T. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-10 · Cited by 491
The role of the gut microbiota in nonalcoholic fatty liver disease
Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457
Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease
SAID, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.010 · Cited by 437
Improved patient survival after acute variceal bleeding: a multicenter, cohort study
Chalasani, N. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)06016-1 · Cited by 400
McDonald, G. B., Slattery, J. T., Bouvier, M. E., Ren, S., Batchelder, A. L., Kalhorn, T. F., Schoch, H. G., Anasetti, C., & Gooley, T. (2003) · Blood · doi:10.1182/blood-2002-06-1860 · Cited by 383
Lichtinghagen, R., Pietsch, D., Bantel, H., Manns, M. P., Brand, K., & Bahr, M. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.016 · Cited by 370
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.019 · Cited by 350
Epidemiology of cystic fibrosis-related diabetes
Marshall, B. C., Butler, S. M., Stoddard, M., Moran, A. M., Liou, T. G., & Morgan, W. J. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.039 · Cited by 327
Pathogenesis and Outcome of Biliary Atresia: Current Concepts
Sokol, R. J., Mack, C., Narkewicz, M. R., & Karrer, F. M. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2003.tb08098.x · Cited by 309
Clinical Biochemistry of Hepatotoxicity
P Sharma, O. (2014) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s4-001 · Cited by 305
Korman, J. D., Volenberg, I., Balko, J., Webster, J., Schiodt, F. V., Squires, R. H., Fontana, R. J., Lee, W. M., & Schilsky, M. L. (2008) · Hepatology · doi:10.1002/hep.22446 · Cited by 305
Drug-induced liver injury: Summary of a single topic clinical research conference
Watkins, P. B., & Seeff, L. B. (2006) · Hepatology · doi:10.1002/hep.21095 · Cited by 279
Farnsworth, N., Fagan, S. P., Berger, D. H., & Awad, S. S. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2004.07.034 · Cited by 266
Nakazawa, T., Ohara, H., Sano, H., Aoki, S., Kobayashi, S., Okamoto, T., Imai, H., Nomura, T., Joh, T., & Itoh, M. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)02229-1 · Cited by 266
Mas, A., Rodés, J., Sunyer, L., Rodrigo, L., Planas, R., Vargas, V., Castells, L., Rodrı́guez-Martı́nez, D., Fernández-Rodrı́guez, C., Coll, I., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00350-1 · Cited by 256
Tabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00495.x · Cited by 52
Immune-mediated drug-induced liver disease
Liu, Z.-X., & Kaplowitz, N. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00025-9 · Cited by 170
The gut microbiota and the liver. Pathophysiological and clinical implications
Quigley, E. M. M., Stanton, C., & Murphy, E. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.023 · Cited by 133
Johansson, K., Sundström, J., Marcus, C., Hemmingsson, E., & Neovius, M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.83 · Cited by 89
Metadata
- Venue
- Wiley eBooks
- Publisher
- Wiley
- Published
- 2017-10-23
- OpenAlex
- W1551808514
- Cited by
- 499
- References
- 0
- FWCI
- 18.15
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.